C2675518||adiponectin deficiency
C0002395||Alzheimer's disease
C0338656||cognitive impairments
C0030664||pathologies
C2350345||AMPK
C0006104||cerebral
C0021655||insulin resistance
C0026809||mice
C0021655||Insulin resistance
C0699748||pathogenesis
C0011860||type 2 diabetes mellitus
C0011860||type 2 diabetes mellitus
C0002395||Alzheimer's disease
C0002395||Alzheimer's disease
C0021655||insulin resistance
C0699748||pathogenesis
C0244989||GSK3β
C0014429||activation
C0175996||intra-
C0521119||extracellular
C0389071||Adiponectin
C0389071||Adiponectin
C1955907||adipokine
C0389071||Adiponectin
C0021655||insulin resistance
C0011860||type 2 diabetes mellitus
C0389071||Adiponectin
C0002395||Alzheimer's disease
C2603343||study
C2675518||adiponectin deficiency
C0006104||cerebral
C0021655||insulin resistance
C0338656||cognitive decline
C0699748||Alzheimer's-like pathology
C0026809||mice
C2603343||study
C0389071||adiponectin
C0392335||cognitive functions
C1522225||adiponectin-knockout
C0206745||(APN-KO) mice
C2675518||APN deficiency
C3714787||CNS
C0683444||Behavioral tests
C2603343||study
C0009240||cognitions
C0206745||APN-KO mice
C0006104||Brains
C0040300||tissue
C2603343||study
C1148560||molecular changes
C0006104||brain
C0206745||APN-KO mice
C0007600||SH-SY5Y neuroblastoma cell line
C2603343||study
C3537153||molecular mechanism
C0389071||Adiponectin
C0389071||Adiponectin
C0026809||mice
C0814087||spatial memory
C0023185||learning
C0684336||impairments
C0233794||memory deficit
C0003467||anxiety
C0026809||mice
C0002395||Alzheimer's disease
C0699748||pathologies
C0006104||cerebral
C0169424||Aβ42
C0085401||hyperphosphorylated Tau proteins
C3686874||microgliosis
C0017639||astrogliosis
C0006104||cerebral
C0021753||IL-1β
C1456820||TNFα
C1660771||neuronal apoptosis
C0229984||synaptic
C0428479||proteins levels
C2675518||APN deficiency
C0006104||brain
C0002395||Alzheimer's disease
C0389071||Adiponectin
C0206745||KO mice
C2350345||AMPK
C0031715||phosphorylation
C1512804||insulin signaling
C0014442||Akt
C0244989||GSK3β
C0014429||activation
C0019564||hippocampus
C0016733||frontal cortex
C0389071||Adiponectin
C0026809||mice
C0019564||hippocampal
C0021655||insulin resistance
C0014442||pAkt
C0199782||insulin injection
C0389071||Adiponectin
C0087111||treatment
C0021655||insulin resistance
C1171362||overexpressing
C0014442||pAkt
C1259440||AdipoR1
C0028778||blocked
C1706082||compound C
C0389071||Adiponectin
C0920563||insulin sensitivity
C2350345||AMPK
C2675518||APN deficiency
C2350345||AMPK
C0699748||AD-like pathogenesis
C0026809||mice
C0338656||cognitive impairments
C0233401||psychiatric symptoms